Furthermore, our investigation revealed the downregulation of AML-target genes, namely CCND2, MYC, NPM1, FLT3, and TERT, upon treatment with 8-OHD, as confirmed by RT-qPCR. The gene discussed is CCND2; the disease is acute myeloid leukemia.